Evidence map›Paper›PMID 34078642›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2021

Cytokine Levels at Birth in Children Who Developed Acute Lymphoblastic Leukemia.

Todd P Whitehead, Joseph L Wiemels, Mi Zhou, Alice Y Kang, Lucie S McCoy, Rong Wang, Briana Fitch, Lauren M Petrick, Yukiko Yano, Partow Imani and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 12 citations in OpenAlex.

  1. Detection of AdenoviralInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Todd P Whitehead *School of Public Health, University of California, Berkeley, Berkeley, California. toddpwhitehead@berkeley.edu.
Joseph L Wiemels *Keck School of Medicine, University of Southern California, Los Angeles, California.ORCID 0000-0003-4838-9951
Mi ZhouSchool of Medicine, University of California, San Francisco, San Francisco, California.
Alice Y KangSchool of Public Health, University of California, Berkeley, Berkeley, California.
Lucie S McCoySchool of Medicine, University of California, San Francisco, San Francisco, California.
Rong WangYale School of Public Health, Yale University, New Haven, Connecticut.
Briana FitchSchool of Medicine, University of California, San Francisco, San Francisco, California.
Lauren M PetrickIcahn School of Medicine, Mount Sinai, New York, New York.ORCID 0000-0003-3493-7419
Yukiko YanoSchool of Public Health, University of California, Berkeley, Berkeley, California.
Partow ImaniSchool of Public Health, University of California, Berkeley, Berkeley, California.
Stephen M RappaportSchool of Public Health, University of California, Berkeley, Berkeley, California.
Gary V DahlLucile Salter Packard Children's Hospital, Stanford University, Palo Alto, California.
Scott C KoganSchool of Medicine, University of California, San Francisco, San Francisco, California.ORCID 0000-0002-2395-8479
Xiaomei MaYale School of Public Health, Yale University, New Haven, Connecticut.
Catherine MetayerSchool of Public Health, University of California, Berkeley, Berkeley, California.ORCID 0000-0003-3467-4145
Berkeley Public Health Division · USUniversity of California, San Francisco · USYale University · USIcahn School of Medicine at Mount Sinai · USLucile Packard Children's Hospital · USUniversity of Southern California · US

Funding

Training CoreP42ES004705 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI SMITH, MARTYN T · 1987 to 2025
$74.6M
Environmental and Molecular Epidemiology of Childhood LeukemiaR01ES009137 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI METAYER, CATHERINE · 1999 to 2013
$21.1M
Project 3 - Prenatal Exposures, Constitutive Genetics, DNA Methylation & Childhood LeukemiaP50ES018172 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI METAYER, CATHERINE · 2015 to 2019
$3.8M
Project 3: Prenatal Exposure, DNA Methylation & Childhood LeukemiaP01ES018172 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI METAYER, CATHERINE · 2009 to 2013
$3.7M
Impact of low IL-10 levels at birth and leukemia riskR01CA185058 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KOGAN, SCOTT C., WIEMELS, JOSEPH LEO · 2014 to 2018
$3.1M
Support For Infrastructure of Childhood Leukemia Environmental ResearchR24ES028524 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI Catherine Metayer · 2017 to 2026
$2.3M
NCI NIH HHS R01 CA185058NIEHS NIH HHS P01 ES018172NIEHS NIH HHS P42 ES004705NIEHS NIH HHS P50 ES018172NIEHS NIH HHS R01 ES009137NIEHS NIH HHS R24 ES028524
6 · The paper itself

Abstract

backgroundPrenatal immune development may play an important role in the etiology of childhood acute lymphoblastic leukemia (ALL).

methodsSeven cytokines, IL1β, IL4, IL6, IL8, GM-CSF, TNFα, and VEGF, were analyzed in blood spots collected at birth from 1,020 ALL cases and 1,003 controls participating in the California Childhood Leukemia Study. ORs and 95% confidence intervals (95% CI) associated with an interquartile range increment in cytokine levels were calculated using logistic regression, adjusting for sociodemographic and birth characteristics.

resultsWe found that patients with ALL were born with higher levels of a group of correlated cytokines than controls [IL1β: OR of 1.18 (95% confidence interval [CI], 1.03-1.35); IL8: 1.19 (1.03-1.38); TNFα: 1.15 (1.01-1.30); VEGF: 1.16 (1.01-1.33)], especially among children of Latina mothers (ORs from 1.31 to 1.40) and for ALL with high hyperdiploidy (ORs as high as 1.27). We found that neonatal cytokine levels were correlated with neonatal levels of endogenous metabolites which had been previously associated with ALL risk; however, there was no evidence that the cytokines were mediating the relationship between these metabolites and ALL risk.

conclusionsWe posit that children born with altered cytokine levels are set on a trajectory towards an increased risk for subsequent aberrant immune reactions that can initiate ALL. IMPACT: This is the first study to evaluate the interplay between levels of immunomodulatory cytokines at birth, prenatal exposures, and the risk of childhood ALL.

Indexed as

BiomarkersCaliforniaCase-Control StudiesCytokinesFemaleHumansInfant, NewbornMaleNeonatal ScreeningPrecursor Cell Lymphoblastic Leukemia-LymphomaRisk FactorsBiomarkersCytokines

Identifiers

PMID34078642
PMCPMC8338848
OpenAlexW3165766949

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.